Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Additionally we are shipping Cyclin L1 Kits (15) and Cyclin L1 Proteins (5) and many more products for this protein.
Showing 10 out of 51 products:
Human Polyclonal Cyclin L1 Primary Antibody for ELISA, IHC - ABIN4288910
Loyer, Trembley, Katona, Kidd, Lahti: Role of CDK/cyclin complexes in transcription and RNA splicing. in Cellular signalling 2005
CCNL1 (show MCM2 Antibodies) is the target gene of miR (show MLXIP Antibodies)-199b-5p.
Data indicate that if the newborn carried a risk allele rs900400 near LEKR/CCNL1 (show MCM2 Antibodies), the impact of stress on birth size was stronger.
birth weight lowering effect of the C-allele of rs900400 located near LEKR1 and CCNL1 (show MCM2 Antibodies) was replicated in the Danish population. Furthermore the C-allele was associated with increased insulin (show INS Antibodies) response following oral glucose stimulation
Data show low birth weight in Asian Indians is not due to variation near CCNL1 (show MCM2 Antibodies)/ADCY5 (show ADCY5 Antibodies), but variant ADCY5 (show ADCY5 Antibodies) is associated with elevated glucose/decreased insulin (show INS Antibodies) response which suggests a common genetic cause of low birth weight and risk of type 2 diabetes.
These data demonstrate that there is a fine balance between CCNL1 (show MCM2 Antibodies) and TIMP1 (show TIMP1 Antibodies), which may contribute to breast cancer development.
Our results suggest that a genetic variant of ccnl1 (show MCM2 Antibodies) leads to symmetric growth restriction from early pregnancy onward
Cyclin L1 amplification is associated with uterine cervical carcinoma.
variants in ADCY5 (show ADCY5 Antibodies) and near CCNL1 (show MCM2 Antibodies) are associated with fetal growth and birth weight
Cyclin L has been shown to associate with the PITSLRE (show CDK11A Antibodies) kinase and is involved in pre-mRNA processing (show PRPF39 Antibodies).
Our results indicate that CCNL1 (show MCM2 Antibodies) plays a critical role in the loco-regional progression of HNSCC and may serve as an indicator for occult advanced tumour stages.
Transcriptional regulator which participates in regulating the pre-mRNA splicing process. Seems to be involved in the regulation of RNA polymerase II (pol II). Functions in association with cyclin-dependent kinases (CDKs) and has a role in the second step of splicing. May be a candidate proto-oncogene in head and neck squamous cell carcinomas (HNSCC). Inhibited by the CDK-specific inhibitor p21.
, cyclin L ania-6a
, cyclin L gamma
, cyclin ania-6a
, cyclin Ania-6a
, minichromosome maintenance complex component 2